🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are encouraged to message these accounts directly for supplier links, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Additionally, a flourishing trade exists on Telegram, where communities with thousands of members share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors market the drug there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, doctors and chemists have warned that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in individuals injecting substances of uncertain source.

Some experts said the demand for retatrutide could be linked to the increasing cost of approved weight loss products such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for human use under the British medical regulations.

Some content creators try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach medicines, advertising, and consumer laws, risking penalties, prosecution or prison.

Platform Response and Content Removal

Based on the social media company, the platform has removed violative content and banned associated hashtags and query recommendations. The company stated it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.

Digital Trading Activities

Research also found communities with up to 9,000 members selling the experimental drug using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, filled with photos of slimming results, glowing testimonials and detailed guides for mixing or administering at home.

Within minutes of entering one group, a vendor shared contact information, where the majority of transactions take place. The vendor provided an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage.

Item Information and Pricing

Within these groups, messages show black plastic parcels with postal service stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service said it regularly moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they can’t verify. Although the research behind retatrutide is sound, these digital versions may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has previously encountered individuals harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet authorized … may subject patients to possibly significant health risks”.